Fibroblast response to gadolinium: role for platelet-derived growth factor receptor.
Fibroblast response to gadolinium: role for platelet-derived growth factor receptor.
复制标题
DOI:
10.1097/rli.0b013e3181e943d2
复制
发表时间:
2010-12
影响因子:
6.7
通讯作者:
Varani J
中科院分区:
文献类型:
--
作者:
Bhagavathula N;Dame MK;DaSilva M;Jenkins W;Aslam MN;Perone P;Varani J
The purpose of this study was to assess the effects of gadolinium (Gd3+), provided as gadolinium chloride, on fibroblast function. Human dermal fibroblasts in monolayer culture and intact skin in organ culture were exposed to the lanthanide metal (1-20 μM). Increased proliferation was observed, in association with up-regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinases-1 (TIMP-1), without an apparent increase in production of type I procollagen. A PDGF receptor-blocking antibody inhibited fibroblast proliferation in response to Gd3+ as did inhibitors of signaling pathways – i.e., mitogen-activated protein (MAP) kinase and phosphatidylinositol-3 (PI3) kinase pathways – that are activated by PDGF. The responses to gadolinium chloride are similar to responses previously seen with chelated Gd3+ in clinically-used MRI contrast agents. Fibroblast responses appear to reflect Gd3+ - induced PDGF receptor activation and down-stream signaling. Increased dermal fibroblast proliferation in conjunction with effects on MMP-1 and TIMP-1 could contribute to the fibroplastic / fibrotic changes seen in the lesional skin of individuals with nephrogenic systemic fibrosis.